abinScience provides high-quality recombinant proteins, validated monoclonal antibodies, and RUO ELISA kits specifically for multiple sclerosis research, focusing on key therapeutic targets (CD20, ITGA4, S1PR1, BTK), leukocyte markers, neurotrophic factors (BDNF), and remyelination-related proteins (LINGO1). Every lot is released with detailed CoA documenting purity, endotoxin, linearity, spike-recovery and precision. For research use only (RUO).
Purity ≥98% • Native pairing • Ideal for adhesion assays
High affinity • Low endotoxin • Clinical-grade mimic
Validated LoD/LoQ • CSF & serum protocols • High precision
B-cell depletion with anti-CD20 therapies (e.g., ocrelizumab) is highly effective; reagents targeting CD20, CD19, and BTK enable studies of B-cell roles in antigen presentation and autoantibody-independent pathology.
ITGA4 blockade prevents lymphocyte entry into CNS; S1PR1 modulation traps lymphocytes in lymph nodes. Corresponding recombinant proteins and antibodies support mechanistic research.
All products are for Research Use Only (RUO) and are not intended for use in diagnostic procedures.
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, FCM, IF
Mouse
IgG2a, kappa
FMC63
Human
FCM
Mouse
IgG1, kappa
SAA0024
Human
FCM
Mouse
IgG2b, kappa
SAA0007
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Mouse
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Mouse
IgG1-kappa
Mammalian Cells
P31358
Met1-Ser36
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Homo sapiens (Human)
Mammalian Cells
P11836
Glu213-Pro297
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Homo sapiens (Human)
Mammalian Cells
P01589
Met1-Gln240
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Homo sapiens (Human)
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Chimeric
IgG1-kappa